Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

By D. Ettinger, D. Wood, D. Aisner, W. Akerley, J. Bauman, A. Bharat, D. Bruno, Joe Y. Chang, L. Chirieac, T. D’amico and 32 more. The Journal of the National Comprehensive Cancer Network, 2022

1,126 citations recorded by the source corpus.

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and actionable mutations.

Subfields: Cancer Research, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/38d4d2adc8ffdacc52300e54e23fafde030780fb